FIELD: medicine.
SUBSTANCE: invention represents an agent for preventing and treating prostatitis and prostate adenoma in the form of a capsule, which contains doxazosin, diisopropylammonium dichroloacetate, afobazol, copper glycinate, vitamin E (d-alpha tocopherol acetate), zinc glycinate; L-Glutamine; L-Alanine; L-Arginine and excipients: corn starch and talc.
EFFECT: extended range of products for treating and preventing prostatitis and prostate adenoma.
4 ex, 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| TREATMENT METHOD OF BENIGN HYPERPLASIA OF PROSTATE GLAND | 2008 |
|
RU2368408C1 |
| METHOD OF TREATING BENIGN PROSTATIC HYPERPLASIA | 2009 |
|
RU2408399C1 |
| METHOD FOR DETECTING THE TYPE FOR TREATING PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA | 2001 |
|
RU2205001C2 |
| METHOD FOR TREATING BENIGN HYPERPLASIA OF PROSTATE | 1996 |
|
RU2125425C1 |
| METHOD FOR TREATING PATIENTS SUFFERING FROM BENIGN HYPERPLASIA OF THE PROSTATE | 2003 |
|
RU2250748C2 |
| METHOD OF DIAGNOSING HYPERACTIVE URINARY BLADDER IN PATIENTS WITH PROSTATE ADENOMA | 2014 |
|
RU2567607C2 |
| PHARMACEUTICAL COMPOSITION FOR TREATING PROSTATE DISEASES (VERSIONS) | 2009 |
|
RU2430733C2 |
| METHOD FOR INTERMITTENT THERAPY IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA | 2013 |
|
RU2531944C1 |
| TETRAPEPTIDE REGULATING PROSTATE FUNCTION, PHARMACOLOGICAL AGENT BASED ON THEREOF AND METHOD OF ITS USING | 2001 |
|
RU2177802C1 |
| METHOD OF TREATING CHRONIC ABACTERIAL PROSTATITIS | 2012 |
|
RU2478408C1 |
